Cargando…
Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review)
Left heart disease is the main cause of clinical pulmonary arterial hypertension (PAH). Common types of left heart disease that result in PAH include heart failure, left ventricular systolic dysfunction, left ventricular diastolic dysfunction and valvular disease. It is currently believed that mecha...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388838/ https://www.ncbi.nlm.nih.gov/pubmed/32582962 http://dx.doi.org/10.3892/ijmm.2020.4650 |
_version_ | 1783564379824848896 |
---|---|
author | Ye, Wenfeng Guo, Haixu Xu, Jinrong Cai, Shuyun He, Yuan Shui, Xiaorong Huang, Shian Luo, Hui Lei, Wei |
author_facet | Ye, Wenfeng Guo, Haixu Xu, Jinrong Cai, Shuyun He, Yuan Shui, Xiaorong Huang, Shian Luo, Hui Lei, Wei |
author_sort | Ye, Wenfeng |
collection | PubMed |
description | Left heart disease is the main cause of clinical pulmonary arterial hypertension (PAH). Common types of left heart disease that result in PAH include heart failure, left ventricular systolic dysfunction, left ventricular diastolic dysfunction and valvular disease. It is currently believed that mechanical pressure caused by high pulmonary venous pressure is the main cause of myocardial infarction (MI) in individuals with ischemic cardiomyopathy and left ventricular systolic dysfunction. In the presence of decreased cardiac function, vascular remodeling of pulmonary vessels in response to long-term stimulation by high pressure in turn leads to exacerbation of PAH. However, the underlying pathological mechanisms remain unclear. Elucidating the association between the development of MI and PAH may lead to a better understanding of potential risk factors and better disease treatment. In this article, the pathophysiological effects of multiple systems in individuals with MI and PAH were reviewed in order to provide a general perspective on various potential interactions between cardiomyocytes and pulmonary vascular cells. |
format | Online Article Text |
id | pubmed-7388838 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-73888382020-08-05 Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review) Ye, Wenfeng Guo, Haixu Xu, Jinrong Cai, Shuyun He, Yuan Shui, Xiaorong Huang, Shian Luo, Hui Lei, Wei Int J Mol Med Articles Left heart disease is the main cause of clinical pulmonary arterial hypertension (PAH). Common types of left heart disease that result in PAH include heart failure, left ventricular systolic dysfunction, left ventricular diastolic dysfunction and valvular disease. It is currently believed that mechanical pressure caused by high pulmonary venous pressure is the main cause of myocardial infarction (MI) in individuals with ischemic cardiomyopathy and left ventricular systolic dysfunction. In the presence of decreased cardiac function, vascular remodeling of pulmonary vessels in response to long-term stimulation by high pressure in turn leads to exacerbation of PAH. However, the underlying pathological mechanisms remain unclear. Elucidating the association between the development of MI and PAH may lead to a better understanding of potential risk factors and better disease treatment. In this article, the pathophysiological effects of multiple systems in individuals with MI and PAH were reviewed in order to provide a general perspective on various potential interactions between cardiomyocytes and pulmonary vascular cells. D.A. Spandidos 2020-09 2020-06-18 /pmc/articles/PMC7388838/ /pubmed/32582962 http://dx.doi.org/10.3892/ijmm.2020.4650 Text en Copyright: © Ye et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Ye, Wenfeng Guo, Haixu Xu, Jinrong Cai, Shuyun He, Yuan Shui, Xiaorong Huang, Shian Luo, Hui Lei, Wei Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review) |
title | Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review) |
title_full | Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review) |
title_fullStr | Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review) |
title_full_unstemmed | Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review) |
title_short | Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review) |
title_sort | heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (review) |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388838/ https://www.ncbi.nlm.nih.gov/pubmed/32582962 http://dx.doi.org/10.3892/ijmm.2020.4650 |
work_keys_str_mv | AT yewenfeng heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview AT guohaixu heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview AT xujinrong heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview AT caishuyun heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview AT heyuan heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview AT shuixiaorong heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview AT huangshian heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview AT luohui heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview AT leiwei heartlungcrosstalkinpulmonaryarterialhypertensionfollowingmyocardialinfarctionreview |